BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25489055)

  • 1. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
    Iliodromiti S; Anderson RA; Nelson SM
    Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice.
    La Marca A; Sunkara SK
    Hum Reprod Update; 2014; 20(1):124-40. PubMed ID: 24077980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
    Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth.
    Nelson SM; Fleming R; Gaudoin M; Choi B; Santo-Domingo K; Yao M
    Fertil Steril; 2015 Aug; 104(2):325-32. PubMed ID: 26003269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.
    Fleming R; Seifer DB; Frattarelli JL; Ruman J
    Reprod Biomed Online; 2015 Oct; 31(4):486-96. PubMed ID: 26283017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
    Tadros T; Tarasconi B; Nassar J; Benhaim JL; Taieb J; Fanchin R
    Fertil Steril; 2016 Dec; 106(7):1800-1806. PubMed ID: 27692436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
    Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
    Gynecol Endocrinol; 2014 Jul; 30(7):490-3. PubMed ID: 24641676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.
    van Disseldorp J; Lambalk CB; Kwee J; Looman CW; Eijkemans MJ; Fauser BC; Broekmans FJ
    Hum Reprod; 2010 Jan; 25(1):221-7. PubMed ID: 19840990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
    Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
    J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.